In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) product approval (Drug Safety Policy Division No. 6698, effective date 2009.9.30), the precautions for use of Cardil XL extended-release tablets 4mg have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Cardil XL extended-release tablet 4mg
Attachments are original documents and may be in Korean. English editions are labeled separately.
Cardil XL Seobangjeong.hwpCardil XL Seobangjeong.hwp · 19 KBDownload ↓